Suzhou Junjing BioSciences Co., Ltd.
Suzhou Junjing BioSciences Co., Ltd.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations | non-small cell lung carcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-07 | NCT06940401 | |
| A Study to Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined With Ruxolitinib in Patients With Myelofibrosis | Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly | Active, not recruiting | Phase 1 / Phase 2 | 2026-03-30 | NCT06909136 |